Which medication is administered intravenously to a patient with multiple sclerosis for spasticity?

Which medication is administered intravenously to a patient with multiple sclerosis for spasticity?

• A. Baclofen
• B. Cyclobenzaprine
• C. Colchicine
• D. Methocarbamol

Answer: (D)

The key idea is the route of administration for treating spasticity. Some muscle relaxants are used mainly by mouth or via specialized delivery (like intrathecal pumps), while others can be given intravenously for rapid effect in acute settings. Methocarbamol is the option that is commonly administered IV, making it suitable for acute muscle spasm relief in a hospital setting for a patient with MS. The others are not typically given intravenously for spasticity: baclofen is standard for MS spasticity but is used orally or intrathecally rather than IV; cyclobenzaprine is mainly an oral agent; colchicine is used for gout and inflammatory conditions, not as a muscle relaxant for spasticity. So, intravenous administration points to methocarbamol as the best fit for this scenario.

The key idea is the route of administration for treating spasticity. Some muscle relaxants are used mainly by mouth or via specialized delivery (like intrathecal pumps), while others can be given intravenously for rapid effect in acute settings.

Methocarbamol is the option that is commonly administered IV, making it suitable for acute muscle spasm relief in a hospital setting for a patient with MS. The others are not typically given intravenously for spasticity: baclofen is standard for MS spasticity but is used orally or intrathecally rather than IV; cyclobenzaprine is mainly an oral agent; colchicine is used for gout and inflammatory conditions, not as a muscle relaxant for spasticity.

So, intravenous administration points to methocarbamol as the best fit for this scenario.